Agilent announced immunoassay kit to detect SARS-CoV-2 antibodies
On Feb. 18, 2021, Agilent Technologies announced the launch of the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay…
On Feb. 18, 2021, Agilent Technologies announced the launch of the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay…
On Feb. 12, 2021, Moderna announced that the Canadian Government had increased its confirmed order commitment by 4…
On Feb. 2, 2021, Novavax announced a memorandum of understanding (MOU) with the Canadian government to produce NVX-CoV2373,…
On Jan. 29, 2021, Rigel Pharma announced it has been awarded $16.5 million by the U.S. Department of…
On Jan. 22, 2021, Novavax announced that it had finalized an agreement with the Government of Canada to…
On Jan. 21, 2021, VBI Vaccines announced that it expected to initiate the first Phase 1/2 clinical study…
On Jan. 14, 2021, Cepheid that Health Canada announced that it had issued Cepheid a medical device license…
On Jan. 13, 2021, SIGA Technologies announced that the Public Health Agency of Canada had awarded a contract…
On Dec. 23, 2020, Moderna announced that Health Canada had authorized its vaccine against COVID-19 for the immunization…
On Dec. 7, 2020, Moderna announced that the Canadian Government had increased its confirmed order commitment by 20…
On Dec. 4, 2020, VBI Vaccines and Syneos Health announced a partnership for the commercialization of VBIメs 3-antigen…
On Nov. 23, 2020, Merck, known as MSD outside the U.S. and Canada, announced the company had submitted…
On Nov. 20, 2020, Eli Lilly announced that Health Canada had granted authorization under the Interim Order Respecting…
On Nov. 10, 2020, BD (Becton, Dickinson) announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the…
On Oct. 29, 2020, AquaBounty Technologies announced that it had identified Mayfield, Kentucky as the potential location for…
On Oct. 23, 2020, Entos Pharmaceuticals announced it was receiving advisory services and funding of up to $5…
On Oct. 13, 2020, RedHill Biopharma announced collaborations with two specialist pharmaceutical manufacturers in Europe and Canada to…
On Oct. 13, 2020, Moderna announced initiation of a rolling submission to Health Canada for mRNA-1273, the Company’s…
On Oct. 9, 2020, Pfizer and BioNTech announced the initiation of a rolling submission to Health Canada for…
On Oct. 8, 2020, SIGA Technologies announced that the Public Health Agency of Canada (PHAC) has issued an…
On Sept. 24, 2020, the U.S. Department of Health and Human Services and the U.S. Food and Drug…
On Sept. 22, 2020, Sanofi and GSK announced they had signed agreements with the Government of Canada for…
On Sept. 1, 2020, Sanofi announced that the global Phase 3 trial investigating intravenously administered Kevzara (sarilumab) at…
On Aug. 31, 2020, Novavax announced it had reached an agreement in principle with the Government of Canada…
On Aug. 5, 2020, Pfizer Canada and BioNTech announced an agreement with the Government of Canada to supply…
On Aug. 5, 2020, Variation Biotechnologies, an Ottawa-based subsidiary of VBI Vaccines, announced that it had been awarded…
On Jul. 22, 2020, through the Canadian COVID Genomics Network (CanCOGeN) ‘a new initiative was launched by Genome…
On Jul. 21, 2020, BD (Becton, Dickinson) announced additional pandemic orders for needles and syringes from the U.S….
On Jun. 30, 2020, AquaBounty Technologies announced it had successfully commenced the commercial-scale harvest of conventional Atlantic salmon…
On Jun. 25, 2020, the Government of Canada announced the results of that funding competition: an investment of…